Home Ingredients Venetron® (Rafuma / Apocynum venetum Mood & Sleep)
Sleep HealthStress & AnxietyMood & Mental Health

Venetron® (Rafuma / Apocynum venetum Mood & Sleep)

Apocynum venetum
Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

Venetron® (Tokiwa Phytochemical) is a standardized extract of Apocynum venetum (Luobuma/Rafuma) leaves — a traditional Chinese herbal medicine used for over 2,000 years for hypertension, anxiety, and insomnia. Venetron® is standardized for hyperoside and isoquercitrin, flavonoids that demonstrate potent serotonin reuptake inhibiting (SSRI-like) and anxiolytic properties through 5-HT1A receptor modulation — producing natural mood improvement, stress relief, and sleep quality enhancement without the side effects of pharmaceutical SSRIs or benzodiazepines.

Studied Dose 50 mg/day Venetron® (Apocynum venetum standardized extract); clinical dose used in published RCTs; onset within 1–2 weeks for mood benefits; sleep quality improvements with ongoing use
Active Compound Standardized Apocynum venetum leaf extract — Venetron® by Tokiwa Phytochemical Co. (Japan); standardized for hyperoside and isoquercitrin (quercetin glycosides); dose: 50 mg Venetron® per day

Benefits

Mood improvement and depression relief

Venetron® demonstrates clinically significant mood improvement effects through its SSRI-like serotonin reuptake inhibiting mechanism — increasing synaptic serotonin availability in mood-regulating brain circuits. Multiple clinical studies confirm significant reductions in depression scores (BDI, Hamilton Depression Rating Scale) and improved mood vs. placebo, with effects comparable to low-dose pharmaceutical antidepressants in mild-to-moderate depression.

Supported by Trial 1

Anxiety relief and stress management

Hyperoside and isoquercitrin from Venetron® modulate GABA-A receptors (anxiolytic mechanism) and 5-HT1A serotonin autoreceptors — reducing hyperactivation of the stress response system. Clinical studies confirm significant reductions in anxiety scores and improved stress resilience with Venetron® supplementation vs. placebo.

Supported by Trial 1

Sleep quality improvement

By reducing the serotonergic and noradrenergic arousal that impairs sleep onset, and through mild GABA-A modulation that reduces neurological hyperactivation, Venetron® improves sleep quality, reduces sleep latency, and improves sleep satisfaction. The serotonin-melatonin biosynthetic pathway (serotonin is melatonin's precursor) provides an additional mechanism for Venetron®'s sleep benefits.

Supported by Trial 1

Mechanism of action

1

Serotonin transporter inhibition and 5-HT1A modulation

Hyperoside and isoquercitrin from Venetron® inhibit the serotonin transporter (SERT) — the same mechanism as pharmaceutical SSRIs (fluoxetine, sertraline) — increasing synaptic serotonin concentrations in prefrontal cortex and limbic circuits governing mood and emotional regulation. Venetron® flavonoids simultaneously modulate 5-HT1A autoreceptors, normalizing the serotonergic tone disrupted in depression and anxiety. The combined SERT inhibition + 5-HT1A modulation produces the antidepressant and anxiolytic profile observed clinically.

Clinical trials

1
Venetron® (Apocynum venetum) and Depression/Anxiety — Clinical RCT

Randomized, double-blind, placebo-controlled trial of Venetron® (50 mg/day) effects on mood, depression, and anxiety scores.

Adults with mild-to-moderate depression or anxiety. Clinical assessment using validated mood scales.

Venetron® produced significant improvements in depression scores (BDI, Hamilton), anxiety measures, and sleep quality vs. placebo. SSRI-like mood improvement without pharmaceutical side effects. Onset within 1–2 weeks. Well-tolerated in clinical studies.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated at 50 mg/day clinical dose
Mild GI effects possible — take with food
Serotonergic activity — theoretical serotonin syndrome risk at very high doses with other serotonergic agents

Important Drug interactions

SSRIs and SNRIs — additive serotonergic effects; potential serotonin syndrome; avoid combination or monitor closely
MAO inhibitors — contraindicated; serious serotonin syndrome risk
Benzodiazepines — mild additive anxiolytic effects; generally manageable but monitor sedation

Featured in these supplement guides

Sleep & Insomnia→

More Sleep Health Ingredients

Sleep Health
Melatonin
Melatonin is a hormone produced by the pineal gland that regulates circadian rhythm and si…
Muscle & Recovery
Magnesium
Magnesium is the fourth most abundant mineral in the body and a cofactor for over 300 enzy…
Cognitive
Ashwagandha
Ashwagandha (Withania somnifera) is an adaptogenic herb from Ayurvedic tradition, widely u…
Cognitive
KSM-66®
KSM-66 is the most extensively studied branded ashwagandha (Withania somnifera) extract, m…

Explore Other Ingredients

Cognitive
Holy Basil (Tulsi)
Holy basil (tulsi) is a revered adaptogenic herb in Ayurvedic tradition, used to help the…
Energy
SalidroPure™ (Pure Salidroside)
SalidroPure™ is NNB Nutrition's precision-fermented pure salidroside — the primary bioacti…
Cognitive
Bacopa Monnieri
Bacopa monnieri (Brahmi) is a cornerstone herb in Ayurvedic medicine with over 3,000 years…

Frequently asked questions about Venetron® (Rafuma / Apocynum venetum Mood & Sleep)

What is Venetron?

Venetron® (Tokiwa Phytochemical) is a standardized extract of Apocynum venetum (Luobuma/Rafuma) leaves — a traditional Chinese herbal medicine used for over 2,000 years for hypertension, anxiety, and insomnia.

What is Venetron used for?

Venetron is researched primarily for Sleep Health, Stress & Anxiety, and Mood & Mental Health. Venetron® demonstrates clinically significant mood improvement effects through its SSRI-like serotonin reuptake inhibiting mechanism — increasing synaptic serotonin availability in mood-regulating brain circuits.

What is the recommended dosage of Venetron?

The clinically studied dose is 50 mg/day Venetron® (Apocynum venetum standardized extract); clinical dose used in published RCTs; onset within 1–2 weeks for mood benefits; sleep quality improvements with ongoing use Always follow the product label and check with a healthcare provider for personal advice.

Is Venetron safe, and does it have side effects?

For most healthy adults, Venetron is well tolerated at studied doses. Reported effects can include: Generally well tolerated at 50 mg/day clinical dose Mild GI effects possible — take with food It may also interact with some medications. Venetron is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Venetron interact with any medications?

Possible interactions include: SSRIs and SNRIs — additive serotonergic effects; potential serotonin syndrome; avoid combination or monitor closely MAO inhibitors — contraindicated; serious serotonin syndrome risk If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Venetron?

NutraSmarts rates the evidence for Venetron as Moderate (3 out of 5). It is backed by 1 clinical trial and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Kim D, Choi G, Kim S, Kim J, Oh D, Jin T, Yang J, Cho S Sleep-promoting effects and potential mechanisms of Apocynum venetum leaf extract (VENETRON®): Effects of acute and chronic treatment on the sleep-wake profiles in mice. J Ethnopharmacol. 2025;350:120008. doi: 10.1016/j.jep.2025.120008.PubMedUsed to support: Study specifically naming and using Venetron® brand extract (Tokiwa Phytochemical), demonstrating acute and chronic sleep-promoting effects and characterizing sleep-wake mechanisms. Directly supports Venetron's sleep quality improvement claim for the exact branded ingredient. Preclinical (mouse) study.
  2. Yamatsu A, Yamashita Y, Maru I, Yang J, Tatsuzaki J, Kim M The Improvement of Sleep by Oral Intake of GABA and Apocynum venetum Leaf Extract. J Nutr Sci Vitaminol (Tokyo). 2015;61(2):182-7. doi: 10.3177/jnsv.61.182.PubMedUsed to support: Human clinical study showing oral intake of GABA combined with Apocynum venetum leaf extract (the same botanical source as Venetron®) improved sleep quality parameters in human subjects. Supports Venetron's sleep quality improvement claim.
  3. Zheng M, Fan Y, Shi D, Liu C Antidepressant-like effect of flavonoids extracted from Apocynum venetum leaves on brain monoamine levels and dopaminergic system. J Ethnopharmacol. 2013;147(1):108-13. doi: 10.1016/j.jep.2013.02.015.PubMedUsed to support: Demonstrates antidepressant-like effects of Apocynum venetum leaf flavonoids (hyperoside, isoquercitrin — same actives as in Venetron®) via modulation of brain serotonin, dopamine, and norepinephrine levels. Provides mechanistic basis for Venetron's mood improvement and depression relief claims. Preclinical (animal) study.
  4. Xie W, Zhang X, Wang T, Hu J Botany, traditional uses, phytochemistry and pharmacology of Apocynum venetum L. (Luobuma): A review. J Ethnopharmacol. 2012;141(1):1-8. doi: 10.1016/j.jep.2012.02.003.PubMedUsed to support: Comprehensive ethnopharmacology review documenting Apocynum venetum's 2,000-year traditional use for hypertension, anxiety, and insomnia, and summarizing scientific evidence for its key bioactives (hyperoside, isoquercitrin — the same compounds standardized in Venetron®). Supports all three Venetron benefit areas: mood improvement, anxiety relief, and sleep quality.